cbdMD (YCBD)
(Delayed Data from AMEX)
$0.54 USD
+0.02 (4.51%)
Updated Sep 17, 2024 12:05 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
YCBD 0.54 +0.02(4.51%)
Will YCBD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for YCBD based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Other News for YCBD
Marijuana Stock Movers For September 4, 2024
American views on marijuana effects worsening: Gallup
Cannabis Stock Gainers And Losers From August 28, 2024
cbdMD receives notice from NYSE regaining listing compliance
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024